A detailed history of Aqr Capital Management LLC transactions in Xencor Inc stock. As of the latest transaction made, Aqr Capital Management LLC holds 21,118 shares of XNCR stock, worth $528,161. This represents 0.0% of its overall portfolio holdings.

Number of Shares
21,118
Previous 39,791 46.93%
Holding current value
$528,161
Previous $753,000 43.69%
% of portfolio
0.0%
Previous 0.0%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$15.7 - $21.65 $293,166 - $404,270
-18,673 Reduced 46.93%
21,118 $424,000
Q2 2024

Aug 14, 2024

BUY
$18.21 - $24.5 $724,594 - $974,879
39,791 New
39,791 $753,000
Q2 2023

Aug 14, 2023

SELL
$24.77 - $29.9 $231,946 - $279,983
-9,364 Reduced 44.43%
11,711 $292,000
Q1 2023

May 15, 2023

SELL
$25.95 - $36.95 $122,717 - $174,736
-4,729 Reduced 18.33%
21,075 $587,000
Q4 2022

Feb 14, 2023

BUY
$24.79 - $30.86 $388,508 - $483,637
15,672 Added 154.68%
25,804 $671,000
Q3 2022

Nov 14, 2022

SELL
$24.62 - $32.44 $144,322 - $190,163
-5,862 Reduced 36.65%
10,132 $263,000
Q2 2022

Aug 15, 2022

BUY
$19.74 - $29.01 $105,253 - $154,681
5,332 Added 50.01%
15,994 $438,000
Q1 2022

May 16, 2022

BUY
$26.68 - $41.63 $284,462 - $443,859
10,662 New
10,662 $284,000
Q4 2021

Feb 14, 2022

SELL
$33.67 - $43.44 $313,871 - $404,947
-9,322 Closed
0 $0
Q3 2021

Nov 15, 2021

SELL
$30.65 - $35.68 $8,214 - $9,562
-268 Reduced 2.79%
9,322 $304,000
Q2 2021

Aug 16, 2021

BUY
$34.33 - $44.68 $69,895 - $90,968
2,036 Added 26.95%
9,590 $331,000
Q1 2021

May 17, 2021

SELL
$40.81 - $53.88 $63,214 - $83,460
-1,549 Reduced 17.02%
7,554 $325,000
Q4 2020

Feb 16, 2021

SELL
$36.63 - $47.63 $879,120 - $1.14 Million
-24,000 Reduced 72.5%
9,103 $397,000
Q3 2020

Nov 16, 2020

SELL
$30.09 - $43.02 $7,612 - $10,884
-253 Reduced 0.76%
33,103 $1.28 Million
Q2 2020

Aug 17, 2020

BUY
$27.76 - $33.42 $347,499 - $418,351
12,518 Added 60.07%
33,356 $1.08 Million
Q1 2020

May 15, 2020

SELL
$20.69 - $37.79 $246,914 - $450,985
-11,934 Reduced 36.42%
20,838 $623,000
Q4 2019

Feb 14, 2020

SELL
$32.75 - $41.43 $227,547 - $287,855
-6,948 Reduced 17.49%
32,772 $1.13 Million
Q3 2019

Nov 14, 2019

BUY
$33.73 - $46.27 $977,596 - $1.34 Million
28,983 Added 269.94%
39,720 $1.34 Million
Q2 2019

Aug 14, 2019

SELL
$29.6 - $40.93 $337,854 - $467,175
-11,414 Reduced 51.53%
10,737 $439,000
Q1 2019

May 14, 2019

SELL
$27.85 - $38.09 $1.02 Million - $1.4 Million
-36,630 Reduced 62.32%
22,151 $688,000
Q4 2018

Feb 14, 2019

SELL
$32.39 - $42.05 $138,629 - $179,974
-4,280 Reduced 6.79%
58,781 $2.13 Million
Q3 2018

Nov 15, 2018

BUY
$35.69 - $47.65 $1.16 Million - $1.54 Million
32,389 Added 105.6%
63,061 $2.46 Million
Q2 2018

Aug 14, 2018

BUY
$28.41 - $42.41 $602,093 - $898,795
21,193 Added 223.58%
30,672 $1.14 Million
Q1 2018

May 15, 2018

SELL
$21.18 - $33.78 $165,521 - $263,990
-7,815 Reduced 45.19%
9,479 $284,000
Q4 2017

Feb 14, 2018

SELL
$19.29 - $24.83 $1.53 Million - $1.97 Million
-79,470 Reduced 82.13%
17,294 $379,000
Q3 2017

Nov 14, 2017

BUY
$19.61 - $23.35 $1.9 Million - $2.26 Million
96,764
96,764 $2.22 Million

Others Institutions Holding XNCR

About Xencor Inc


  • Ticker XNCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,698,100
  • Market Cap $1.49B
  • Description
  • Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...
More about XNCR
Track This Portfolio

Track Aqr Capital Management LLC Portfolio

Follow Aqr Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aqr Capital Management LLC with notifications on news.